Evaxion Biotech A/S (EVAX)
NASDAQ: EVAX · Real-Time Price · USD
1.835
+0.075 (4.26%)
Mar 31, 2025, 2:22 PM EDT - Market open
Evaxion Biotech Stock Forecast
EVAX's stock price has decreased by -88.56% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Evaxion Biotech stock have an average target of 33.33, with a low estimate of 6.00 and a high estimate of 80. The average target predicts an increase of 1,716.35% from the current stock price of 1.84.
Analyst Consensus: Strong Buy
* Price targets were last updated on Feb 20, 2025.
Analyst Ratings
The average analyst rating for Evaxion Biotech stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +662.94% | Feb 20, 2025 |
| Lake Street | Lake Street | Strong Buy Maintains $35 → $6 | Strong Buy | Maintains | $35 → $6 | +226.98% | Feb 4, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +662.94% | Feb 3, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $140 | Strong Buy | Reiterates | $140 | +7,529.43% | Nov 1, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $140 | Strong Buy | Reiterates | $140 | +7,529.43% | Sep 26, 2024 |
Financial Forecast
Revenue This Year
6.67M
from 73.00K
Increased by 9,039.73%
Revenue Next Year
6.77M
from 6.67M
Increased by 1.47%
EPS This Year
-5.89
from -40.47
EPS Next Year
-2.24
from -5.89
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 6.9M | 13.9M | 27.9M | |||
| Avg | 6.7M | 6.8M | 20.3M | |||
| Low | 6.4M | n/a | 13.1M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 9,308.2% | 108.9% | 311.8% | |||
| Avg | 9,039.7% | 1.5% | 200.4% | |||
| Low | 8,680.8% | - | 93.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -0.84 | -1.39 | 0.72 | |||
| Avg | -5.89 | -2.24 | 0.70 | |||
| Low | -10.53 | -3.02 | 0.68 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.